$46.12
-0.89-1.89%
Últ. Act.: Oct 27, 1:24 PM
Omega Healthcare Invts (OHI) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Omega Healthcare Invts (OHI) emitió su última guía sobre julio 29, 2026 para fiscal year 2026. La compañía estimó unas ganancias por acción en el rango de $3.22 - $3.26, en comparación con una estimación de consenso de EPS de $3.1.
En comparación con la previsión anterior, Omega Healthcare Invts mantenido redujo su previsión de BPA desde un rango anterior de $3.19 - $3.25.
Omega Healthcare Invts ha emitido 11 actualizaciones de orientación entre el febrero 7, 2024 y el julio 29, 2026. During this period, the company raised its outlook 7 times, reflecting management's growing confidence in business performance.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.77 | $0.77 | $0.60 | $0.56 |
| Actual | $0.83 | $0.82 | $0.80 | $0.79 |
| Surprise | +7.79% | +6.49% | +33.3% | +41.1% |
| Revenue | ||||
| Estimate | $283.1M | $276.6M | $288.4M | $280.4M |
| Actual | $328.2M | $323.0M | $319.2M | $311.6M |
| Surprise | +15.9% | +16.8% | +10.7% | +11.1% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $0.78 | $0.79 | $0.80 | $0.80 |
| Revenue | ||||
| Consensus | $283.0M | $287.1M | — | — |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | Jul 29, 2026 | $0.83 | $0.77 | 7.79 % |
| Q1 | Apr 28, 2026 | $0.82 | $0.77 | 6.49 % |
| Q4 | Feb 4, 2026 | $0.80 | $0.60 | 33.3 % |
| Q3 | Oct 30, 2025 | $0.79 | $0.56 | 41.1 % |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q2 | Jul 29, 2026 | $328.25M | $283.13M | 15.9 % |
| Q1 | Apr 28, 2026 | $322.96M | $276.56M | 16.8 % |
| Q4 | Feb 4, 2026 | $319.22M | $288.42M | 10.7 % |
| Q3 | Oct 30, 2025 | $311.59M | $280.39M | 11.1 % |